• Covid-19 and Cancer - Publications and abstracts list from taskforce members including the recent Lancet Oncology publication "Cancer and COVID-19 vaccines: a complex global picture" available via the link below.

  • Covid-19 and Cancer intelligence hub, hosted by ecancer: Rapid reports are critical for getting data in the public domain in these unprecedented times. The intelligence hub serves as a single point of access to current literature, current impact case studies and emerging reports. We encourage you to contribute.

  • Group members are engaged in wide variety of research projects investigating the impact of the COVID-19 crisis on Cancer:

  • The COVID-19 and Cancer Global Modelling Consortium (CCGMC) brings together the global modelling community to support decision-making in cancer control both during and after the crisis. Our aim is to help to configure modelling platforms and teams that can provide more informed advice to our governments, particularly those in low- and middle-income countries, as they rise to this overwhelming health systems challenge. Our focus on the longer-term, as well as the shorter-term, recognises that recovery strategies will be required as countries move beyond the acute phase of the crisis. See more for the details of the three areas of work we are prioritizing.

  • A series of webinars from the taskforce members covering the latest developments in covid and cancer


The coronavirus (COVID-19) pandemic has created massive downward pressure on social, economic and health systems across the world. Cancer patients in all countries and settings have been directly and indirectly impacted.

The Covid-19 and Cancer Taskforce is a globally representative group of cancer leaders spanning the disciplines of cancer across the care continuum from prevention, early detection, treatment and palliative, to representatives of cancer centre networks and advocacy groups.

We are gravely concerned that decisions made under the duress of the pandemic will have momentous consequences for cancer mortality for years to come. National measures are meaning access and availability of timely, affordable and equitable care is under grave threat.

We wish to work with and draw on the expertise of the global cancer community, alongside those of infectious disease and other non-communicable disease, to ensure that data is captured and research conducted to a high quality to:

  • Assess the immediate impacts on cancer patients, services, and healthcare workers as well as treatment decision making and patient/doctor interactions;
  • Address risks for longer term impacts on cancer outcomes, inequalities, research and affordability;
  • Develop an integrated approach to build resilient cancer services with readiness to respond to new pandemics, especially in low- and middle-income countries whose; cancer services are especially vulnerable in the face of this unprecedented public health challenge.